These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10911542)

  • 41. Treatment of urinary tract infections with cephalexin.
    Erikssen J; Midtvedt T; Bergan T
    Scand J Infect Dis; 1970; 2(1):53-8. PubMed ID: 5520522
    [No Abstract]   [Full Text] [Related]  

  • 42. [Ceftriaxone: pharmacokinetics, pharmacodynamics. Application in the treatment of acute otitis media in children].
    Bergogne-Bérézin E
    Presse Med; 1997 Nov; 26(37):1827-34. PubMed ID: 9569905
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical evaluation of cephalexin monohydrate in the treatment of infections of the genitourinary system].
    Aspe AJ
    Prensa Med Mex; 1970; ():45-50. PubMed ID: 4931116
    [No Abstract]   [Full Text] [Related]  

  • 44. Pyelonephritis and female urinary tract infection.
    Shea DJ
    Emerg Med Clin North Am; 1988 Aug; 6(3):403-17. PubMed ID: 3292219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A prospective, randomized, double dummy, placebo-controlled trial of oral cefditoren pivoxil 400mg once daily as switch therapy after intravenous ceftriaxone in the treatment of acute pyelonephritis.
    Monmaturapoj T; Montakantikul P; Mootsikapun P; Tragulpiankit P
    Int J Infect Dis; 2012 Dec; 16(12):e843-9. PubMed ID: 22951426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The efficacy and safety of tazobactam/ceftolozane in Japanese patients with uncomplicated pyelonephritis and complicated urinary tract infection.
    Arakawa S; Kawahara K; Kawahara M; Yasuda M; Fujimoto G; Sato A; Yokokawa R; Yoshinari T; Rhee EG; Aoyama N
    J Infect Chemother; 2019 Feb; 25(2):104-110. PubMed ID: 30420153
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pyelonephritis].
    Takayasu S; Terawaki Y
    Naika; 1967 Jun; 19(6):1129-32. PubMed ID: 4865503
    [No Abstract]   [Full Text] [Related]  

  • 48. [Antibiotic therapy of acute pyelonephritis: which treatment to offer?].
    Gaudelus J
    Arch Pediatr; 1999; 6 Suppl 2():403s-405s. PubMed ID: 10370550
    [No Abstract]   [Full Text] [Related]  

  • 49. [Studies on synergistic action against penicillin and cephalosporin resistant bacteria. II: Clinical evaluations of synergistic action in urinary tract infections].
    Suzuki K
    Nihon Hinyokika Gakkai Zasshi; 1970 May; 61(5):473-84. PubMed ID: 5200441
    [No Abstract]   [Full Text] [Related]  

  • 50. Vitamin A supplementation is effective for improving the clinical symptoms of urinary tract infections and reducing renal scarring in girls with acute pyelonephritis: a randomized, double-blind placebo-controlled, clinical trial study.
    Kahbazi M; Sharafkhah M; Yousefichaijan P; Taherahmadi H; Rafiei M; Kaviani P; Abaszadeh S; Massoudifar A; Mohammadbeigi A
    Complement Ther Med; 2019 Feb; 42():429-437. PubMed ID: 30670279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renal effects of cephacetrile in man, in healthy and diseased subjects.
    Mioli V; Vangelista 'A; Albertazzi A; Bortolotti GC; Bonomini V
    Arzneimittelforschung; 1974 Sep; 24(9b):1504-5. PubMed ID: 4479812
    [No Abstract]   [Full Text] [Related]  

  • 52. An update on new antibiotic prophylaxis and treatment for urinary tract infections in children.
    Delbet JD; Lorrot M; Ulinski T
    Expert Opin Pharmacother; 2017 Oct; 18(15):1619-1625. PubMed ID: 28954556
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ceftriaxone for acute otitis media.
    Eppes SC; Klein JD; Lewis LL
    Pediatrics; 1997 Jul; 100(1):157-8. PubMed ID: 9229709
    [No Abstract]   [Full Text] [Related]  

  • 54. [Comparison of the effects of gentamicin and other chemotherapeutic agents in experimental urinary tract infections].
    Prát V; Konícková L
    Cas Lek Cesk; 1970 Apr; 109(17):378-81. PubMed ID: 5443121
    [No Abstract]   [Full Text] [Related]  

  • 55. In vivo susceptibility of ESBL producing Escherichia coli to ceftriaxone in children with acute pyelonephritis.
    Peco-Antić A; Paripović D; Buljugić S; Spasojević-Dimitrijeva B; Cvetković M; Laban-Nestorović S; Milosevski-Lomić G
    Srp Arh Celok Lek; 2012; 140(5-6):321-5. PubMed ID: 22826985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of long-acting cephalosporins in ambulatory therapy.
    Prichard JG
    Clin Ther; 1988; 10(6):688-93. PubMed ID: 3219684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Management of acute pyelonephritis in patients older than 3 months: survey conducted in 39 paediatric emergency departments of the Ile de France Region in 2004].
    de La Vaissière B; Castello B; Quinet B; Cohen R; Grimprel E
    Arch Pediatr; 2006 Mar; 13(3):245-50. PubMed ID: 16386883
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Urinary tract infections in pediatric practice--which new aspects must be considered?].
    Laux-End R; Marchand S; Bianchetti MG
    Ther Umsch; 1998 Jan; 55(1):32-8. PubMed ID: 9492616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ceftriaxone, a new parenteral cephalosporin, in the treatment of urinary tract infections.
    Bernstein Hahn L; Barclay CA; Iribarren MA; Traballi CA
    Chemotherapy; 1981; 27 Suppl 1():75-9. PubMed ID: 7018853
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment by oral route of urinary tract infections in children].
    Bensman A
    Arch Pediatr; 1995 Sep; 2(9):897. PubMed ID: 7581791
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.